Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

CK 5/6 expression in breast cancer is linked to negative hormone receptor status and higher tumor grade.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.

The combination therapy is effective and well-tolerated for treating esophageal cancer.

p14ARF and p16Ink4a cause hair follicle stem cell aging and dysfunction.

The nano-carrier makes etoposide safer and more effective against lung cancer.

Scalp cooling effectively reduces hair loss from chemotherapy.

Skin reactions from cancer treatments might predict how well the treatments work.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

Computational tools identified 29 drugs that could potentially target 19 genes involved in chemotherapy-induced hair loss, which could lead to more effective treatments.

Some breast cancer treatments, like taxanes, can cause long-term hair loss.

The new finasteride delivery system using chitosan-based nanoniosomes shows promise for prostate cancer prevention.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Human dental pulp stem cell-conditioned medium, especially from hypoxic conditions, may help treat chemotherapy-induced hair loss and does not increase cancer risk.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

GLP-1 receptor agonists, like Dulaglutide, Liraglutide, and Semaglutide, have potential benefits beyond the pancreas, including neuroprotection, pain suppression, cardiovascular protection, obesity management, and cancer treatment, but there are concerns about pancreatitis and pancreatic cancer risks.

New therapies are being developed that target integrin pathways to treat various diseases.

New nanocarriers improve drug delivery for disease treatment.